The number of reported serious side effects was 10.43% with semaglutide 14 mg versus 10.56% with placebo.In PIONEER 6,190 the rate of serious adverse side effect was 18.92% with semaglutide 14 mg and 22.50% with placebo.In PIONEER 7,191 the rate of adverse side effect was 49.80% with semaglutide 14 mg versus 28.00% with sitagliptin 100 mg
Editorially reviewed Last updated July 25, 2026 How we review Part of Clinical Trials Tracker
People taking Contrave lost an average of 5% of their body weight, while those on the placebo lost 1.8%
Semaglutide units on a syringe are purely a measurement of volume, not potency
Natural supplements may support metabolic health but do not activate GLP-1 receptors like semaglutide does
Women planning pregnancy should discuss discontinuation timing with their healthcare provider, typically allowing approximately 25 days (five half-lives) for tirzepatide to be substantially eliminated from the body before conception